中国与印度缺血性卒中医疗质量对比:基于国家临床登记研究的结果
本研究比较中国与印度住院缺血性卒中患者的危险因素、急性期管理、质量绩效依从性和临床结局,数据来自印度IUCSP(5家学术卒中中心,n=2,066)和中国CNSR-II(31家学术医院,n=1,973)。印度患者更年轻、卒中更重、静脉溶栓率更高、院内死亡率和3个月不良结局更差,中国患者更多接受抗血栓治疗、卒中教育和吞咽筛查。
要点
- 印度患者卒中更重(中位NIHSS 10 vs 4),3小时静脉溶栓率更高(7.5% vs 2.4%),院内死亡率更高(7.9% vs 1.2%)。
- 中国患者更多接受抗血栓治疗、卒中教育和吞咽筛查。
- 印度患者3个月改良Rankin量表评分0-2的比例更低(49.3% vs 78.1%)。
核心结论
- 这些数据为了解两个亚洲大国学术城市中心的缺血性卒中医疗现状提供了见解,需进一步研究确定这些模式是否代表全国医疗情况、解释观察到的严重程度差异并推动改进。
研究设计与样本
- 比较研究,使用印度IUCSP(5家来自不同地理区域的学术卒中中心,n=2,066)和中国CNSR-II(在31个省份219个参与站点中限定31家学术医院,n=1,973)的住院缺血性卒中患者数据,比较危险因素、急性期管理、质量绩效依从性和临床结局。
主要发现
- 印度患者显著更年轻、医疗保险更少,危险因素不同:更多糖尿病、血脂异常和冠心病,较少既往卒中、高血压、心房颤动和吸烟。
- 印度患者卒中更重(中位NIHSS评分10 vs 4),3小时内静脉溶栓率更高(7.5% vs 2.4%),院内死亡率更高(7.9% vs 1.2%),3个月改良Rankin量表评分0-2的比例更低(49.3% vs 78.1%),所有p<0.001。
- 临床结局较差主要归因于IUCSP患者卒中严重程度更高。
- 中国患者住院期间更多接受抗血栓治疗、卒中教育和吞咽筛查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究以确定这些模式是否代表两国全国医疗情况、解释观察到的严重程度差异并推动改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand stroke risk factors, status of stroke care, and opportunities for improvement as China and India develop national strategies to address their disproportionate and growing burden of stroke. METHODS: We compared stroke risk factors, acute management, adherence to quality performance measures, and clinical outcomes among hospitalized ischemic stroke patients using data from the Indo-US Collaborative Stroke Project (IUCSP) and China National Stroke Registry-II (CNSR-II). The IUCSP included 5 academic stroke centers from different geographic regions (n = 2,066). For comparison, the CNSR-II dataset was restricted to 31 academic hospitals among 219 participating sites from 31 provinces (n = 1,973). RESULTS: Indian patients were significantly younger, had health insurance less often, and had significantly different risk factors (more often diabetes mellitus, dyslipidemia, and coronary heart disease; less often prior stroke, hypertension, atrial fibrillation, and smoking). Hospitalized Indian patients had greater stroke severity (median NIH Stroke Scale score 10 vs 4), higher rates of IV thrombolysis within 3 hours (7.5% vs 2.4%), greater in-hospital mortality (7.9% vs 1.2%), and worse outcome (3-month modified Rankin Scale score 0-2, 49.3% vs 78.1%) (all p < 0.001). The poorer clinical outcomes were attributable mainly to greater stroke severity in IUCSP patients. Chinese patients more often received antithrombotics, stroke education, and dysphagia screening during hospitalization. CONCLUSION: These data provide insights into the status of ischemic stroke care in academic urban centers within 2 large Asian countries. Further research is needed to determine whether these patterns are representative of care across the countries, to explain differences in observed severity, and to drive improvements.
引用
- Li Z, Pandian J, Sylaja PN, et al. Quality of care for ischemic stroke in China vs India: Findings from national clinical registries. Neurology. 2018. PMID: 30158158. doi:10.1212/WNL.0000000000006291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。